Skip to main content

PharmacoEconomics

Ausgabe 9/2011

Inhalt (6 Artikel)

Editorial

Value-Based Pricing

Dyfrig A. Hughes

Leading Article

Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies

Petros Pechlivanoglou, Robin De Vries, Simon M.G.J. Daenen, Maarten J. Postma

Review Article

Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure

Alexander Goehler, Benjamin P. Geisler, Jennifer M. Manne, Beate Jahn, Annette Conrads-Frank, G. Scott Gazelle, Uwe Siebert

Original Research Article

To Fund or Not to Fund

Tania Stafinski, Devidas Menon, Christopher McCabe, Donald J. Philippon

Original Research Article

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand

Naiyana Praditsitthikorn, Yot Teerawattananon, Sripen Tantivess, Supon Limwattananon, Arthorn Riewpaiboon, Saibua Chichareon, Nantakan Ieumwananonthachai, Viroj Tangcharoensathien

Adis Pharmacoeconomic Drug Evaluation

Cinacalcet

Greg L. Plosker